RecruitingPhase 3NCT07116967
Long-Term Safety Study of Deucravacitinib Versus Ustekinumab in Participants With Psoriasis (PRAGMATYK)
Sponsor: Bristol-Myers Squibb
Bexley, OH · Canal Winchester, OH · Canton, OH · +119 more sites
3 recruiting psoriasis studies with a site in Canton, OH.
Sponsor: Bristol-Myers Squibb
Bexley, OH · Canal Winchester, OH · Canton, OH · +119 more sites
Sponsor: Takeda
Canton, OH · Fairborn, OH · Mayfield Heights, OH · +8 more sites
Sponsor: Bristol-Myers Squibb
Canton, OH · Lorain, OH · Mayfield Heights, OH · +44 more sites
Listings come from ClinicalTrials.gov and are provided for information only. Always confirm eligibility with the study team and talk with your doctor before making decisions about your care.